The first precursor stage is monoclonal gammopathy of undetermined significance (MGUS), accompanied by a low blood level of the M-protein as well as the number of clonal plasma cells in the bone marrow being under 10%, where the risk of transition from MGUS to active myeloma is only 1% [3]. Here, MYOM2 is linked to plasma cell myeloma.